Showing 3 of 3 recruiting trials for “Inclusion body myositis”
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
Ruxolitinib Treatment in Inclusion Body Myositis
👨⚕️ François Jérôme AUTHIER, Pr, Assistance Publique - Hôpitaux de Paris📍 16 sites📅 Started May 2025View details ↗
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →